Ajanta Pharma LimitedNSE: AJANTPHARM

Press Release Aug 30 2023

Ajanta Pharma Limited has informed the Exchange regarding a press release dated August 30, 2023, titled "Ajanta receives final approval from US FDA forTopiramate Extended Release Capsules".

View Attachment

Earlier from Ajanta Pharma

All Ajanta Pharma news releases